Product Information

BANOPHEN 25 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0520 per EA under NDC 00904723780. Its NADAC has been published 208 times since Nov 23, 2022.

BANOPHEN 25 MG CAPSULE

Diphenhydramine Hydrochloride
$0.0520per EA
OTC

Strength

25 mg/1

NDC

00904723780

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

4/14/2022

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for BANOPHEN 25 MG CAPSULE has been published 208 times since Nov 23, 2022, and over the history we have for it it has risen 53.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0520 per EA
All-time high$0.0640 (Feb 11, 2026)
All-time low$0.0303 (Dec 21, 2022)
52-week high$0.0640
52-week low$0.0520
Median price$0.0437
Average price$0.0462
Largest weekly change+27.5% (Jan 18, 2023)
Weeks tracked208
Tracking sinceNov 23, 2022

Price History

1W

0.0%

1M

-2.5%

3M

-6.7%

6M

-14.0%

1Y

-5.9%

3Y

+12.5%

5Y

N/A

All

+53.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BANOPHEN 25 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BANOPHEN 25 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0520 per EA (NDC 00904723780), effective Nov 11, 2026.

How has the price of BANOPHEN 25 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BANOPHEN 25 MG CAPSULE has risen 53.9%. It has been tracked across 208 weekly CMS publications since Nov 23, 2022.

What are the highest and lowest recorded NADAC prices for BANOPHEN 25 MG CAPSULE?

Since Nov 23, 2022, the NADAC for BANOPHEN 25 MG CAPSULE has ranged from a low of $0.0303 (Dec 21, 2022) to a high of $0.0640 (Feb 11, 2026), with a median of $0.0437 per EA.

Are there cheaper alternatives to BANOPHEN 25 MG CAPSULE?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIPHENHYDRAMINE 25 MG CAPSULE, is $0.0415 per EA — about 20% below BANOPHEN 25 MG CAPSULE.

Who manufactures BANOPHEN 25 MG CAPSULE?

BANOPHEN 25 MG CAPSULE (NDC 00904723780) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.